To assess the feasibility of the combination therapy of C‐REV, an OV, and 2′3′‐cGAMP, an endogenous membrane‐impermeable STING agonist, we first characterized the integrity of the STING pathway in murine tumor cell lines SCCVII, Pan02 and KPC. Here, STING1 is linked to neoplasm.